Work

Adjunctive therapy for multidrug-resistant bacterial infections: Type III secretion system and efflux inhibitors

Year: 2021

Type: review

Source: Drug Discovery Today

DOI: 10.1016/j.drudis.2021.03.031

Authors: Donald T. Moir, Timothy J. Opperman, Zachary D. Aron, Terry L. Bowlin

Institution: Microbiotix (United States)

Language: English

Topic: Antibiotic Resistance in Bacteria

Subfield: Molecular Medicine

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Wellcome Trust, Bundesministerium für Bildung und Forschung, Asian Society for Pediatric Research, National Institutes of Health, Biomedical Advanced Research and Development Authority, National Institute of Allergy and Infectious Diseases

Awards: Validating targets in p. aeruginosa type III secretion using chemical probes, Optimization of novel pyranopyridine efflux pump inhibitors, Antibiotic Potentiators Targeting SOS Induction, G7140082099, Type III Secretion Inhibitors for Anti-Infective Therapy, T3SS needle protein inhibitors for the treatment of P. aeruginosa infection

OpenAlex ID: W3155876301

FWCI: 0.238

Cites: 75

Cited by: 16

Related to: 10